Publications by authors named "Javier Naval"

Claim this Profile
N
NK92 cells stably transfected with CD16 are efficient against multiple myeloma cells and , especially if combined with daratumumab.
David Giraldos, Evelyn Galano-Frutos, Laura Cambronero-Arregui, Manuel Beltrán Visiedo, Eduardo Romanos, Javier Naval

Oncoimmunology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alisertib and Barasertib Induce Cell Cycle Arrest and Mitochondria-Related Cell Death in Multiple Myeloma with Enhanced Efficacy Through Sequential Combination with BH3-Mimetics and Panobinostat.
Andrea Benedi, Manuel Beltrán-Visiedo, Nelia Jiménez-Alduán, Alfonso Serrano-Del Valle, Alberto Anel, Javier Naval

Cancers (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytofluorometric assessment of calreticulin exposure on CD38 plasma cells from the human bone marrow.
Manuel Beltrán-Visiedo, Alfonso Serrano-Del Valle, Nelia Jiménez-Aldúan, Ruth Soler-Agesta, Javier Naval

Methods Cell Biol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dinaciclib synergizes with BH3 mimetics targeting BCL-2 and BCL-X in multiple myeloma cell lines partially dependent on MCL-1 and in plasma cells from patients.
Manuel Beltrán-Visiedo, Nelia Jiménez-Alduán, Rosana Díez, Marta Cuenca, Andrea Benedi, Javier Naval

Mol Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study of the Bcl-2 Interactome by BiFC Reveals Differences in the Activation Mechanism of Bax and Bak.
Óscar Gonzalo, Andrea Benedi, Laura Vela, Alberto Anel, Javier Naval

Cells· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosis.
Alfonso Serrano Del Valle, Manuel Beltrán-Visiedo, Victoria de Poo-Rodríguez, Nelia Jiménez-Alduán, Gemma Azaceta, Javier Naval

Oncoimmunology· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing the Potential of NK Cell-Based Immunotherapies against Multiple Myeloma.
Chantal Reina-Ortiz, David Giraldos, Gemma Azaceta, Luis Palomera, Isabel Marzo, Javier Naval

Cells· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Future prospects for mitosis-targeted antitumor therapies.
Alfonso Serrano-Del Valle, Chantal Reina-Ortiz, Andrea Benedi, Alberto Anel, Javier Naval

Biochem Pharmacol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IFNα signaling through PKC-θ is essential for antitumor NK cell function.
Natalia R Comet, Juan Ignacio Aguiló, Moeez G Rathoré, Elena Catalán, Johan Garaude, Javier Naval

Oncoimmunology· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanded NK cells from umbilical cord blood and adult peripheral blood combined with daratumumab are effective against tumor cells from multiple myeloma patients.
Chantal Reina-Ortiz, Michael Constantinides, Alexis Fayd-Herbe-de-Maudave, Jessy Présumey, Javier Hernandez, Javier Naval

Oncoimmunology· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanded and activated allogeneic NK cells are cytotoxic against B-chronic lymphocytic leukemia (B-CLL) cells with sporadic cases of resistance.
Tania Calvo, Chantal Reina-Ortiz, David Giraldos, María Gascón, Daniel Woods, Javier Naval

Sci Rep· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Forms of Immunomodulation for Cancer Therapy.
Alfonso Serrano-Del Valle, Javier Naval, Alberto Anel, Isabel Marzo

Trends Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response: Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma.
Alfonso Serrano Del Valle, Alberto Anel, Javier Naval, Isabel Marzo

Front Cell Dev Biol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A giant retroperitoneal liposarcoma with renal involvement: A case report and literature review.
Andrea Montenegro, Modesto Varas, Elena Sánchez-Vizcaíno, Javier Naval, Carmen Loras

Gastroenterol Hepatol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenic Cell Death and Immunotherapy of Multiple Myeloma.
Alfonso Serrano-Del Valle, Alberto Anel, Javier Naval, Isabel Marzo

Front Cell Dev Biol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Importance of TRAIL Molecular Anatomy in Receptor Oligomerization and Signaling. Implications for Cancer Therapy.
Javier Naval, Diego de Miguel, Ana Gallego-Lleyda, Alberto Anel, Luis Martinez-Lostao

Cancers (Basel)· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Exosomes in the Regulation of T-cell Mediated Immune Responses and in Autoimmune Disease.
Alberto Anel, Ana Gallego-Lleyda, Diego de Miguel, Javier Naval, Luis Martínez-Lostao

Cells· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of autophagy with chloroquine potentiates carfilzomib-induced apoptosis in myeloma cells in vitro and in vivo.
Vidal Jarauta, Paula Jaime, Oscar Gonzalo, Diego de Miguel, Ariel Ramírez-Labrada, Javier Naval

Cancer Lett· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative proteomics of exosomes secreted by tumoral Jurkat T cells and normal human T cell blasts unravels a potential tumorigenic role for valosin-containing protein.
Alberto Bosque, Lisa Dietz, Ana Gallego-Lleyda, Manuel Sanclemente, María Iturralde, Javier Naval

Oncotarget· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
potential of recombinant granulysin against human tumors.
Sameer Al-Wasaby, Diego de Miguel, Adriana Aporta, Javier Naval, Blanca Conde

Oncoimmunology· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human NK cells activated by EBV lymphoblastoid cells overcome anti-apoptotic mechanisms of drug resistance in haematological cancer cells.
Diego Sánchez-Martínez, Gemma Azaceta, Aura Muntasell, Nacho Aguiló, David Núñez, Javier Naval

Oncoimmunology· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MHC-I modulation due to changes in tumor cell metabolism regulates tumor sensitivity to CTL and NK cells.
Elena Catalán, Seyma Charni, Paula Jaime, Juan Ignacio Aguiló, José Antonio Enríquez, Javier Naval

Oncoimmunology· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulysin induces apoptotic cell death and cleavage of the autophagy regulator Atg5 in human hematological tumors.
Adriana Aporta, Elena Catalán, Patricia Galán-Malo, Ariel Ramírez-Labrada, Marta Pérez, Javier Naval

Biochem Pharmacol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimitotic drugs in cancer chemotherapy: promises and pitfalls.
Isabel Marzo, Javier Naval

Biochem Pharmacol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liposomes decorated with Apo2L/TRAIL overcome chemoresistance of human hematologic tumor cells.
Diego De Miguel, Gorka Basáñez, Diego Sánchez, Patricia Galán Malo, Isabel Marzo, Javier Naval

Mol Pharm· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis